Mercury from centuries-old pollution still circulating in oceans, study finds
A paper published Thursday in Nature Communications sought to untangle a paradox: why levels of the potent neurotoxin mercury in Arctic whales and polar bears are increasing — despite steps the world has taken to curb mercury pollution.
Those levels are now 20 to 30 times higher in Arctic wildlife than they were before the industrial era began, even as global mercury pollution has fallen since the 1970s.
'We've monitored mercury in Arctic animals for over 40 years. Despite declining global emissions since the 1970s, we see no corresponding decrease in Arctic concentrations — on the contrary,' coauthor Rune Dietz of Aarhus University, said in a statement.
The researchers' conclusion: mercury released by pollution hundreds of years ago is still circulating in ocean currents, which convey it up to the Arctic.
The findings come amid reports that the Trump administration is seeking to overturn rules limiting the release of mercury from U.S. power plants — a step that reverses a long campaign to slow its accumulation in the atmosphere.
If these U.S. changes take place, the findings suggest, they will continue to contaminate the environment well into the 2300s.
Mercury — particularly forms that have been processed by bacteria — wreaks havoc on the brain and body, disrupting the ability of humans and animals to move, sense and think.
While a global effort has been successful in cutting levels of mercury in the atmosphere, Thursday's findings point to a mystery: Levels of the toxin in the muscle and tissue of top predators like seals and polar bears are still going up.
In addition to being released into the environment from burning fossil fuels, mercury is also used to purify gold extracted in small-scale or wildcat mining — a practice that is still common in the world's forests, but has significantly decreased from its 19th Century peak.
In gold rushes like those in 1850s California or the modern Amazon, miners used mercury to bind together gold together from a slurry of dirt and ore, and then burn it off to leave pure gold — sending the mercury into the atmosphere.
From there, mercury rains down onto the land and flows into lakes and rivers, where bacteria break it down — as well as into the oceans, where that breakdown can take as much as 300 years.
The same quality that lets mercury pull together gold flakes gives it an insidious role in the environment because animals cannot easily purge it from their bodies.
That means mercury levels concentrate in the bodies of top predators — whether bears or humans.
The long duration of mercury in oceans gives it time to make its own epic journey from 19th Century smelters to the modern Arctic, the scientists found.
'Transport of mercury from major sources like China to Greenland via ocean currents can take up to 150 years,' Dietz said.
'This helps explain the lack of decline in Arctic mercury levels.'
Though China is working to phase out mercury mining and pollution from coal, the findings suggest a long lag time.
Even if mercury pollution continues to decrease, the scientists projected, its levels will continue to go up in the Arctic.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
10 hours ago
- Yahoo
Alume Biosciences Announces Publication of Data Examining First-in-Human Use of Bevonescein to Illuminate Nerves in Nature Communications
SAN DIEGO, July 02, 2025--(BUSINESS WIRE)--Alume Biosciences, a late-clinical stage biotechnology company developing nerve-illuminating technology to enhance surgical safety, today announced the publication of first-in-human data from a Phase 1 clinical trial evaluating bevonescein (ALM-488) in head and neck surgeries. The original research article titled, "Intraoperative Nerve-Specific Fluorescence Imaging in Head and Neck Surgery: A Phase 1 Clinical Trial," authored by Lee, Y., Orosco, R., et al., was published in Nature Communications. Bevonescein is a novel fluorescent visualization drug designed to selectively illuminate nerves during surgery, helping to prevent inadvertent nerve injury and is currently being evaluated in ongoing Phase 3 clinical trials. "Currently, many head and neck surgeries result in nerve injuries, which can be catastrophic for the patients," said Eben L. Rosenthal, MD, Barry Baker Professor and Chair of the Department of Otolaryngology–Head and Neck Surgery at Vanderbilt University Medical Center and study senior author. "This first-in-human data demonstrate the safety of bevonescein and its potential to enhance nerve visualization in real time. It's especially promising to see improvements in nerve conspicuity at the optimal dose." Key Findings: Fluorescence Superiority: Bevonescein provided enhanced nerve visualization with higher nerve conspicuity scores in fluorescent compared to white light. All participants demonstrated improved visible nerve length; 57% showed more than 20% improvement. Optimal Dose Defined: The optimal treatment dose of bevonescein was 500mg. Favorable Safety Profile: No dose-limiting toxicities or infusion reactions occurred. No surgeries were delayed or canceled due to the study drug. "These data support our belief that bevonescein can help make surgery more precise by allowing surgeons to see nerves more clearly," said Quyen Nguyen, MD, PhD, Founder and CEO of Alume Biosciences. "When Roger Tsien and I started work on bevonescein, our vision was to translate his Nobel Prize-winning discoveries regarding fluorescence into tools that directly improve surgical outcomes. This milestone brings us closer to that goal." "With the growing adoption of fluorescence guidance in surgery, it's exciting to see this technology now applied to nerve identification," said Ryan Orosco, MD, Associate Professor, University of New Mexico and the study's co-lead author. "Bevonescein represents a paradigm shift in how we identify nerves during surgery, and ultimately how we improve patient outcomes." Study Overview The dose-defining and dose-timing clinical trial enrolled 27 adults undergoing elective head and neck surgery including parotidectomy, thyroidectomy and cervical neck dissections. Participants received intravenous bevonescein at varying doses to assess safety, pharmacokinetics, and optimal visualization timing. Surgical visualization of bevonescein-enabled nerve fluorescence was performed using the Zeiss Tivato surgical microscope with Yellow 560. Surgeons assessed nerve visualization using 4-point Likert scale that measured conspicuity, visible nerve length, and delineation of branching. About Bevonescein (ALM-488) Bevonescein is Alume's lead compound—a targeted fluorescent peptide-dye conjugate that binds to nerve tissue, enabling intraoperative nerve visualization. It is currently in Phase 3 clinical trials and is planned for New Drug Application (NDA) submission to the U.S. Food and Drug Administration in 2026. About Alume Biosciences Alume Biosciences is a biotechnology company pioneering nerve-targeted drugs to enhance surgical precision and preserve nerve function. Founded on a lead candidate co-invented by late Nobel Laureate Dr. Roger Tsien, Alume is committed to translating cutting-edge science into practical tools for surgeons and better outcomes for patients. Learn more at and LinkedIn. View source version on Contacts Media Contact Janine 201-245-6838 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Miami Herald
14 hours ago
- Miami Herald
Trump's science cuts are great news — for other countries
Of all the questionable things President Trump has done recently — such as starting trade wars with traditional U.S. allies, threatening to invade friendly countries and pushing for bills that would balloon the U.S. deficit — one of the most important, yet least discussed, is his defunding of U.S. science programs. Since the start of his second term on Jan. 20, Trump has set in motion the most sweeping cuts to scientific research in modern U.S. history, including public grants for research into Alzheimer's, cancer and other major diseases. In addition to cutting research funds for leading U.S. universities, such as Harvard and Princeton, Trump's 2026 budget has led to the planned layoffs of thousands of scientists at some of the world's leading scientific institutions. Many U.S. scientists are now moving to Canada and Europe, where leaders in France and other countries have already opened their doors —and their budgets— to America's scientific refugees. A White House document proposing the 2026 budget calls for a 57% reduction for the U.S. National Science Foundation (NSF), which supports basic research in science and engineering, from $9 billion to $3.9 billion. It also calls for a 40% cut in the funding for the National Institutes of Health (NIH), the world's biggest public funder of biomedical research, from $47 billion to $27 billion. To put these figures in perspective, Trump's 'Big, beautiful bill,' which was close to being passed by Congress at the time of this writing, included $45 billion in new funds to build detention facilities — critics call them 'concentration camps' — for undocumented immigrants. As I have shown in previous columns, most current immigration detainees are not violent criminals, but hard-working people seeking a better life. Already, the NIH has canceled more than 2,400 research projects, the respected journal Nature reported on June 27. Trump's budget cuts to U.S. science are 'unprecedented,' and could have 'catastrophic effects,' Nature said in an earlier report on May. 15. The Trump administration says the NIH, NSF, NASA and other government-funded scientific institutions were rife with waste and politically-motivated 'woke' programs, and needed to be made more efficient. Many grants were awarded under non-scientific diversity, equity and inclusion (DEI) requirements that the Trump administration has now terminated, administration officials say. But most scientists say that, while there's probably some degree of waste in any large organization, Trump's budget cuts are a catastrophic overreaction. The administration is killing research programs that could save millions of lives in America and around the world, as well as crippling U.S. innovation in cutting-edge industries. Rep. Bill Foster, D-Illinois, the only member of Congress with a PhD in physics, told me in an interview that 'Trump is wrecking American science.' He added, 'I understand why you would have to cut things, including science. But this is done in a very sloppy and, frankly, stupid way.' Trump's budget cutters have simply looked for science programs that had the terms 'diversity,' or 'inclusion' somewhere in their paperwork, regardless of their merit, critics say. In many cases, such words were just included pro forma in top-quality scientific research programs. Foster told me he already knows of cases in which professors working on five-year research programs have just learned that their last year of funding is being cut off. They have had to lay off their research teams, leading many scientists to seek jobs abroad. 'Right now, America is bleeding scientific talent,' Foster told me. While much of the U.S. scientific leadership was built thanks to European scientists who moved to America in World War II, such as Nobel laureate Albert Einstein, the reverse trend is taking place now, he added. Indeed, French President Emmanuel Macron and European Commission President Ursula von der Leyen recently announced a $566 million plan at Sorbonne University to lure U.S. science refugees. The program is officially called 'Choose Europe for Science.' In an obvious reference to the United States, Macron said at the announcement ceremony that 'Nobody could imagine a few years ago that one of the great democracies of the world would eliminate research programs on the pretext that the word 'diversity' appeared in its program,' according to a New York Times report. When I asked Foster why he thinks Trump is crippling America's scientific programs, he said, 'I think he's trying to achieve popularity with his base, which comes largely from rural areas.' He added that people living in rural areas may not be fully aware of the benefits of science, and are more likely to blame intellectuals and scientists for the country's problems. Maybe so. But whatever the reason, crippling U.S. science will have dire consequences. America will pay not just in lost discoveries, but in lost lives, lost leadership and a diminished future for generations to come. Don't miss the 'Oppenheimer Presenta' TV show on Sundays at 9 pm E.T. on CNN en Español. Blog:


The Hill
16 hours ago
- The Hill
Space Shuttle Discovery would move to Texas under GOP megabill
The Space Shuttle Discovery would move to Texas under President Trump's 'big, beautiful bill,' according to Sen. John Cornyn (R-Texas). Cornyn's office said in a statement on his website that Trump's megabill 'would authorize' Discovery's shipment to 'an entity' close to Houston's Lyndon B. Johnson Space Center. It is currently on display at the Smithsonian's Steven F. Udvar-Hazy Center in Northern Virginia. 'Houston has long been the cornerstone of our nation's human space exploration program, and it's long overdue for Space City to receive the recognition it deserves by bringing the Space Shuttle Discovery home,' Cornyn said in the statement, posted on Monday. 'I am glad to see this pass as part of the Senate's One Big Beautiful Bill and look forward to welcoming Discovery to Houston and righting this egregious wrong,' he added. Discovery, which took its last flight in 2011, spent a year in space while it was in service and travelled almost 150 million miles, according to the Smitsonian 'Houston has long stood at the heart of America's human spaceflight program, and this legislation rightly honors that legacy,' Sen. Ted Cruz (R-Texas) said in Cornyn's release 'It ensures that any future transfer of a flown, crewed space vehicle will prioritize locations that have played a direct and vital role in our nation's manned space program, making Houston, Texas, a leading candidate,' he added. House Republicans advanced the 'big, beautiful bill' early Thursday morning, overcoming an important procedural hurdle toward a final vote following a dramatic vote that Republican leaders left open for hours to calm an internal revolt. The Hill has reached out to the National Air and Space Museum for comment.